About the Authors
- Caroline O. Bush
-
Affiliation Gilead Sciences, Inc., Biology Department, Foster City, California, United States of America
- Andrew E. Greenstein
-
Affiliation Gilead Sciences, Inc., Biology Department, Foster City, California, United States of America
- William E. Delaney IV
-
Affiliation Gilead Sciences, Inc., Biology Department, Foster City, California, United States of America
- Rudolf K. F. Beran
-
* E-mail: rudolf.beran@gilead.com
Affiliation Gilead Sciences, Inc., Biology Department, Foster City, California, United States of America
Competing Interests
All authors are employed by Gilead Sciences, the funder of this study. All authors own stock in Gilead Sciences. None of the drugs or inhibitors used in this study are currently, or were formerly, in development at Gilead Sciences. None of the drugs or inhibitors in this study are marketed products for the treatment of hepatitis C virus by Gilead Sciences. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: RKFB COB AEG WED. Performed the experiments: RKFB COB AEG. Analyzed the data: RKFB COB AEG WED. Contributed reagents/materials/analysis tools: RKFB COB. Wrote the paper: RKFB COB WED.